24_10_STREAM_SiteHeader_OP

2025 CDMO LEADERSHIP AWARDS CEREMONY

Now in its 14th year, the CDMO Leadership Awards, presented by Outsourced Pharma and brought to you by Life Science Connect with research by Orientation Marketing, highlight the industry’s most valued partners, as determined by the customers who use their services. This year’s awards ceremony introduced new categories and many new winners, based on enhanced scoring methodology, and a refined approach based on customer feedback.

Watch our on-demand broadcast of the event that took place on March 19th, 2025 at The POOL in New York City to share in the celebration of the best in the industry!

 

RECENT WEBINARS

40:50 GettyImages-1309776439-scientists-lab-analysis-manufacturing

Critical Path For Gene Therapy: AAV Analytical Lifecycle Considerations

34:22 450_300-viralgen_splash

Raising The Bar In Gene Therapy

44:30 GettyImages-1434627610 lab, manufacturing

Extrusion-Based ASD Scale-Up: Performance Through Process Understanding

1:02:15 Unpacking pDNA Processes: Capacity, Complexity, And Cutting-Edge Solutions Splash

Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions

54:24 The Future Is Now: Are You Keeping Pace With Oligo Synthesis Optimization?

Are You Keeping Pace With Oligo Synthesis Optimization?

1:01:08 CAI - 6 Pillars webinar

From Readiness To Results: Unlocking Capacity For Expanding Product Demand

1:00:20 iStock-938242776-skin-lotion-topical

Advancing Topical Formulations With Innovative Preclinical Models

50:11 Accelerate Your pDNA And mRNA Process Development

Accelerate Your pDNA And mRNA Process Development

26:46 GettyImages-1405590436-lab-perfusion-cleanroom

Driving Robust Tech Transfer In Biologics: CFD Simulation

1:01:06 450_300-img001

Navigating Commercial Cell Therapy Manufacturing

56:31 Enhancing Viral Vector Sterile Filtration: Process Efficiency And GMP Alignment

Enhancing Viral Vector Sterile Filtration: Process Efficiency And GMP Alignment

56:11 Innovations, Solutions, And USP <1062> With Scale Up

Innovations, Solutions, And USP <1062> With Scale Up

More Recent Webinars

SMALL MOLECULE OUTSOURCING

5:04 Adare Pessano Tour

Integration From Formulation Development To Manufacturing, Packaging

1:00:17 Lonza-1

Challenges Of Moving A Bioconjugate Candidate From Clinic To Market

4:02 Luigi Bellone

Cambrex Scientist Spotlight: Luigi Bellone

56:09 Cleanroom Faciliy GettyImages-1087218962

From Bench To Batch: Strategies For Scaling HPAPI Production

56:23 GettyImages-615982934-water

Environmental Sustainability: Wastewater Incineration Reduction

5:16 Jonas Nilsson

Cambrex Scientist Spotlight: Jonas Nilsson

55:26 GettyImages-1401699330-microscope-lab-research-computer

Considerations For Complex Formulations: How To Simplify Your Outsourcing

2:02 GettyImages-950086574-oral-solid-OSD-pill-tablet-capsule-development

Small Molecule APIs: From Pre-RSM To Final API

31:11 GettyImages-1322996506 Capital Equipment In Lab

CESS Technology

40:03 Lonza1

How To Design An HPAPI Plant And Its Containment Systems

4:20 Adare-Feature

Developing Long-Acting Contraceptive Injectables

1:01:17 GettyImages-1354172420-lab-development

Taste Masking 101: Applications And Technologies

More Small Molecule Outsourcing Videos
24_10_STREAM_Brand_Category_Banner_LONZA_top v2
1:00:17 Lonza-1

Challenges Of Moving A Bioconjugate Candidate From Clinic To Market

57:46 Lonza1

Embrace Molecule Complexity With Optimized Expression Technologies

56:23 GettyImages-615982934-water

Environmental Sustainability: Wastewater Incineration Reduction

14:47 GettyImages-1441662840-lab-team-communication-collaboration

Precision Execution Of Bispecifics At Scale From Design To Delivery

1:00:24 GettyImages-517743436-plasmid-dna-development-lab

Tailored CMC Solutions That Meet Needs Of Novel Molecular Biologic Formats

37:57 GettyImages-1404945060-lab-process-cleanroom-research

Expressing Next-Gen Immunotherapies And Other Advanced Biologics

48:58 Lonza2

Mitigate Risk Of Failure In Biotherapeutic Development

46:00 GettyImages-692413188 lab research

Environmental Sustainability: Use Case - Solvent Recovery

1:01:57 1_3B4D2469D8702BB4390B4A926895F65C

Inclusion Bodies: Mother Nature's Help Or Hindrance?

53:38 GettyImages-2017789595 lab, research

Early Preclinical Development: A Successful Transition To cGMP Manufacturing

32:23 1_9CE82855B543B4966E969CE57B550278

DNA To IND In 11 Months: Integrated Drug Substance, Drug Product Offering

40:03 Lonza1

How To Design An HPAPI Plant And Its Containment Systems

More Lonza Videos
24_10_STREAM_Brand_Category_Banner_LONZA_bottom v2

CELL AND GENE OUTSOURCING

25:18 mRNA GettyImages-1356994723

Quantifying Cell Response With Duplex RT-qPCR

1:00:20 Andelyn - AAV Bucket

AAV Analytics: Key Considerations When Developing A Clinical Program

58:56 GettyImages-1214111376 scientists computer

Optimization-By-Design — A Critical Factor In Viral Vector Scale Up

1:00:24 GettyImages-517743436-plasmid-dna-development-lab

Tailored CMC Solutions That Meet Needs Of Novel Molecular Biologic Formats

49:07 IDT Biologika - Vaccine Feature

Viral Vector Manufacturing: Improve Efficiency With A Platform Approach

43:20 GettyImages-1368429013-fill-finish-aseptic

Future-Proof Your Aseptic Filling

1:16:51 West-PFS SYRG-018

Managing Risks In Injectable Drug Delivery

6:08 Get To Know WuXi Advanced Therapies Testing Services

Get To Know Minaris Advanced Therapies Testing Services

2:27 1

Delivering Therapies To Patients At Scale And At Speed

53:38 GettyImages-2017789595 lab, research

Early Preclinical Development: A Successful Transition To cGMP Manufacturing

48:56 Cell And Gene Therapy Development

Cell & Gene Therapy Development: Characterization Of Cellular Starting Material

50:05 West

Selecting Containers For Sensitive And Costly Cell & Gene Therapies

More Cell and Gene Outsourcing Videos

OUTSOURCED PHARMA CAPACITY UPDATE

17:29 Pfizer FF OPCU Oct 2025

Pfizer CentreOne Sterile Injectables Capacity Update October 2025: Fill/Finish

22:25 Pace FF OPCU Oct 2025

Pace Life Sciences Capacity Update October 2025: Fill/Finish

19:37 medac FF OPCU Oct 2025

medac CDMO Capacity Update October 2025: Fill/Finish

17:29 Jubilant FF OPCU Oct 2025

Regulatory Confidence, Manufacturing Excellence

17:53 INCOG FF OPCU OCT 2025

INCOG BioPharma Services Capacity Update October 2025: Fill/Finish

17:59 Argonaut FF OPCU OCT 2025

Argonaut Manufacturing Services Capacity Update October 2025: Fill/Finish

21:06 Alcami FF OPCU OCT 2025

Alcami Capacity Update October 2025: Fill/Finish

24:14 Vector Biomed CGT OPCU October 2025

The Future Of Lentiviral Vector Innovation And Access

27:34 Minaris CGT OPCU October 2025

Minaris Advanced Therapies Capacity Update October 2025: Cell & Gene Therapy

15:50 Ascend CGT OPCU Oct 2025

Ascend & ABL Inc. Capacity Update October 2025: Cell & Gene Therapy

15:56 Andelyn CGT OPCU Oct 2025

Andelyn Biosciences Capacity Update October 2025: Cell & Gene Therapy

22:58 3PBIOVIAN Large Mol October 2025

OPCU October 2025: Large Molecule

Outsourced Pharma Capacity Update Page

BIOLOGIC OUTSOURCING

2:27 1

Delivering Therapies To Patients At Scale And At Speed

1:52 iStock-879831370-plasmid-lab-cell

Rising To Meet Increasing Demand For Microbial Based Biologics

13:18 abzena cc AbZelectPRO thumb

The Next-Gen Cell Line Development Platform Fueling Biologics Success

23:33 fuji safety thumb

Building A Strong Safety Culture In The Biopharmaceutical Industry

11:20 Northway

Biopharmaceuticals Development And Manufacturing: Wide-Ranging Expertise And Vertically Integrated Service

1:32 GettyImages-2036497686-lab-team-collaboration-laboratory-tablet-computer

Discovering A Unique Multimillion Euro Nanotechnology Facility

1:19 Expertise In Commercial Fill-Finish For More Than 30 Years

Expertise In Commercial Fill-Finish For More Than 30 Years

1:09 GettyImages-1444551560-filling-aseptic-fill-finish-line

Handle Your Drug Product With The Highest Quality And Safety

1:39 Aji OPTIMA 7000

OPTIMA 7000 Fill Line

1:35 Ampoule Aseptic Filling GettyImages-1490244818

Delivering Top Quality Fill Finish Manufacturing

1:43 GettyImages-1297146235-dna

Providing Value Optimized, Time Saving Oligo Solutions

0:44 Meeting Needs And Exceeding Expectations Worldwide

Meeting Needs And Exceeding Expectations Worldwide

More Biologic Outsourcing Videos

OUTSOURCED PHARMA LIVE

2:04 Fostering Effective Sponsor–CDMO Collaboration (Trust vs. Oversight)

Fostering Effective Sponsor–CDMO Collaboration (Trust vs. Oversight)

5:30 Avoiding And Mitigating Delays In Outsourced Projects

Avoiding And Mitigating Delays In Outsourced Projects

3:42 Selecting The Right CDMO Partner For Small Molecule Development

Selecting The Right CDMO Partner For Small Molecule Development

3:31 Key Elements Of Effective Tech Transfer Management

Key Elements Of Effective Tech Transfer Management

2:55 Establishing Realistic Development Timelines With A CDMO

Establishing Realistic Development Timelines With A CDMO

4:48 Ensuring Quality And Regulatory Compliance In Outsourced Manufacturing

Ensuring Quality And Regulatory Compliance In Outsourced Manufacturing

59:49 Small Molecule Outsourcing: Getting Timelines, Tech Transfer And Analytics Right

Small Molecule Outsourcing: Getting Timelines, Tech Transfer, And Analytics Right

3:45 Not A Trick Question: How Do You Know When You Have Adequately Established A Reliable Supply Chain?

Not A Trick Question: How Do You Know When You Have Adequately Established A Reliable Supply Chain?

3:01 When To Consolidate CDMOs ... And When You Shouldn't

When To Consolidate CDMOs ... And When You Shouldn't

4:01 The Criticality Of Biannual Overview Meetings With Your Suppliers

The Criticality Of Biannual Overview Meetings With Your Suppliers

3:58 Avoid Complexity In Any Supply Chain

Avoid Complexity In Any Supply Chain

1:31 Are There Countries You Should Avoid When Outsourcing?

Are There Countries You Should Avoid When Outsourcing?

Outsourced Pharma Live Page

OUTSOURCING FUNDAMENTALS

2:54 China Globe World

Global Advantage With Free Trade Zones In China

0:30 Scientist in lab GettyImages-872025342

Collaborating To Craft Efficient Processes

4:23 Catalent-DTP

Understanding Options In Direct-To-Patient Clinical Supply

2:33 GettyImages-171136123-japan

The Ultimate Guide To Clinical Supplies For Japan Studies

0:30 GettyImages-1146473276-team-collaboration-partnership-discussion

Fostering CDMO Collaboration On Both Sides

1:13 23_10_OPL_Challenges_Webinar_Seg01

Workforce Challenges Key To Outsourcing

2:42 Map global Logistics GettyImages-1202209630

Commercial Drug Sourcing For Clinical Trials

0:30 GettyImages-1413600685-lab-team-collaboration-computer-research

Visionary Thinkers And Problem Solvers: The Cambrex Team

1:35 Ampoule Aseptic Filling GettyImages-1490244818

Delivering Top Quality Fill Finish Manufacturing

4:15 23_10_OPL_Challenges_Webinar_Seg02

Managing Multiple Partners – And Materials – From Around The Globe

More Outsourcing Fundamentals Videos

BUSINESS OF BIOTECH

51:32 Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt

Building A Cancer Pipeline In A Molecule With Actuate Therapeutics' Dan Schmitt

58:44 Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.

Biotech Collaboration Strategy With IGI's Cyril Konto, M.D.

57:04 BoB_1280x720_Allan_Shaw

Biotech Funding And IPO Temperature Check With CREATE Medicine's Allan Shaw

46:14 Funding Tips And Moving From R&D To Commercial With Madrigal Pharmaceuticals' Mardi Dier

Funding Tips And Moving From R&D To Commercial With Madrigal Pharmaceuticals' Mardi Dier

42:51 Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D.

Emerging From Stealth With Vima Therapeutics' Bernard Ravina, M.D.

31:47 BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals

BoB in South Florida: Rich Daly, Catalyst Pharmaceuticals

33:34 BoB In South Florida: Anthony Japour, M.D., iTolerance

BoB In South Florida: Anthony Japour, M.D., iTolerance

33:08 BoB In South Florida: Daniel Teper, NAYA Therapeutics

BoB In South Florida: Daniel Teper, NAYA Therapeutics

34:58 BoB In South Florida: Raquel Cabo, Miami Biotech Collective

BoB In South Florida: Raquel Cabo, Miami Biotech Collective

57:58 The Business Case For Health Economics And Outcomes Research With ISPOR's Rob Abbott

The Business Case For Health Economics And Outcomes Research With ISPOR's Rob Abbott

57:27 Cannabinoid And Psychedelic Combinations With Incannex Healthcare's Joel Latham

Cannabinoid And Psychedelic Combinations With Incannex Healthcare's Joel Latham

58:25 Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small

Dye Drug Conjugates For Cancer With Lahjavida's Lyle Small

57:54 Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.

Investing In The Biostack With Modi Ventures' Sahir Ali, Ph.D.

1:04:36 Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.

Improving Cardiovascular Outcomes With Immediate Therapeutics' Atul Deshpande, Ph.D.

52:07 BoB_1280x720_Vladimir_Cmiljanovic

Building A Biotech Incubator And Accelerator With Swiss Rockets Founder And CEO Vladimir Cmiljanovic, Ph.D.

52:37 Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia

Biotech Product Partnership with Coya Therapeutics' Arun Swaminathan, Ph.D. and Dr. Reddy's Milan Kalawadia

58:11 How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak

How To Hire And Build A Winning Executive Team With Occam Global's Bill Holodnak

52:03 The Generalist Biotech CEO With Seekyo's Oury Chetboun

The Generalist Biotech CEO With Seekyo's Oury Chetboun

54:07 BoB_1280x720_Ebrahim_Delpassand

Innovating On The Frontier Of Radiopharmaceuticals With RadioMedix's Ebrahim Delpassand, M.D.

45:41 BoB_1280x720_Ep263

Building An Efficient Biopharma With South Rampart Pharma's Hernan Bazan, M.D.

54:23 24_01_BoB_1280x720_Ep262

The Business And Science Of Obesity With Roger Cone, Ph.D., Founder Of Courage Therapeutics

32:40 24_01_BoB_1280x720_Ep261

BoB Live At BIO: Amber Salzman, Ph.D., Epicrispr Biotechnologies

56:34 24_01_BoB_1280x720_Ep260

How To Be A Policy Advocate For Biotech With NewYorkBIO's Jennifer Hawks Bland

1:04:33 24_01_BoB_1280x720_Ep259

FDA Trials And Tribulations With Connect Biopharma's Barry Quart

58:23 24_01_BoB_1280x720_Ep258_2

Proactive Procurement Strategies For Biotech With Tom Wells

1:06:27 24_01_BoB_1280x720_Ep257

The Discovery Of Microbes And Implications For Public Health Today, With Science Writer Thomas Levenson

55:50 24_01_BoB_1280x720_Ep256

Psychedelics For Mental Health Disorders With atai's Srinivas Rao, M.D., Ph.D.

56:27 24_01_BoB_1280x720_Ep255

Biotech Angel Investing With Yaniv Sneor

59:23 24_01_BoB_1280x720_Ep254

Leading A tRNA Startup With Alltrna's Michelle Werner

39:45 24_01_BoB_1280x720_Ep253

Executing A Product Pivot With Vir's Mark Eisner, MD

55:54 24_01_BoB_1280x720_Ep252

Commercializing RNAi Therapies With Alnylam's Tolga Tanguler

55:45 24_01_BoB_1280x720_Ep251

Big Pharma Insights For Building Biotech Startups With Uniquity Bio's Brian Lortie

46:08 24_01_BoB_1280x720_Ep250

The Implications Of China's Growing Biotech Industry With Allan Shaw

44:20 24_01_BoB_1280x720_Ep249

How To Be A CFO With Insmed's Sara Bonstein

46:43 24_01_BoB_1280x720_Ep248

Deal And Investment Trends With Investment Banker David Sans

34:44 24_01_BoB_1280x720_Ep247

Business of Biotech 2.0 with Ben Comer

43:32 24_01_BoB_1280x720_Ep246

BoB@JPM: Nima Farzan, Latigo Biotherapeutics

43:46 24_01_BoB_1280x720_Ep245

BoB@JPM: Kasper Roet, Ph.D., QurAlis

52:20 24_01_BoB_1280x720_Ep244

BoB@JPM: Rick Modi, Affinia Therapeutics

56:27 24_01_BoB_1280x720_Ep243

BoB@JPM: Owen Hughes & Brad Sitko, XOMA Royalty

47:59 24_01_BoB_1280x720_Ep242

BoB@JPM: Tom Chalberg, Ph.D., Genascence

37:00 24_01_BoB_1280x720_Ep241

BoB@JPM: Ran Zheng, Landmark Bio

45:07 24_01_BoB_1280x720_Ep240

BoB@JPM: Peter Anastasiou, Capsida Biotherapeutics

43:00 24_01_BoB_1280x720_Ep239

BoB@JPM: Stefan Scherer, M.D., Ph.D., 3T Bioscience

47:50 24_01_BoB_1280x720_Ep238

The Business Of CNS with Acumen's Jim Doherty, Ph.D.

1:13:36 24_01_BoB_1280x720_Ep237

High-Throughput Discovery With BIOPTIC's Andrey Dobry

1:06:32 24_01_BoB_1280x720_Ep236

RNA Sandbox with Johns Hopkins RNA Innovation Center's Jeff Coller, Ph.D. and Michelle Kim, Ph.D.

54:04 24_01_BoB_1280x720_Ep235

Biotech Story Time With Tal Zaks, M.D. (Part 2)

1:02:34 24_01_BoB_1280x720_Ep234

Risk Mitigation With MeiraGTx's Zandy Forbes, Ph.D.

55:25 24_01_BoB_1280x720_Ep233

Biotech Story Time With Tal Zaks, M.D. (Part 1)

52:50 24_01_BoB_1280x720_Ep232

A $1B AI Bet With Foresite Labs' Vik Bajaj, Ph.D.

1:03:50 24_01_BoB_1280x720_Ep231

Manufacturing Partnership With Life Biosciences Jerry McLaughlin and Forge Biologics' John Maslowski

45:26 24_01_BoB_1280x720_Ep230

Novel Peptide Delivery With Revolo's Woody Bryan, Ph.D.

49:54 24_01_BoB_1280x720_Ep229

Biopolitics With Allan Shaw

1:01:35 24_01_BoB_1280x720_Ep228

T-Cells For The Win With Adaptimmune's Adrian Rawcliffe

46:48 24_01_BoB_1280x720_Ep227

Serving The Underserved With Gates MRI's Claire Wagner, M.D.

49:12 24_01_BoB_1280x720_Ep226

An Unanticipated Biotech Startup With OS Therapies' Paul Romness

44:14 24_01_BoB_1280x720_Ep225

Building On Pandemic Progress With Barinthus Biotherapeutics' Bill Enright

1:02:40 24_01_BoB_1280x720_Ep224

Obesity Tx End-Around With Skye Bioscience's Punit Dhillon

51:34 24_01_BoB_1280x720_Ep223

Biotech C-Suite Construction With Allan Shaw

59:19 24_01_BoB_1280x720_Ep222

The Peptide Promise With NervGen's Mike Kelly

1:17:16 24_01_BoB_1280x720_Ep221

Biotech Course Correction With Treehill Partners' Ali Pashazadeh

1:14:26 24_01_BoB_1280x720_Ep220

An AI Awakening With Profluent Bio's Hilary Eaton, Ph.D.

54:05 24_01_BoB_1280x720_Ep218

Embracing Biotech Chaos With Memo's Erik van den Berg

1:04:47 24_01_BoB_1280x720_Ep217

Pivoting To RNA With Circio's Dr. Erik Digman Wiklund

1:03:07 24_01_BoB_1280x720_Ep216

mRNA Upstarts With Radar Therapeutics' Sophia Lugo and Eerik Kaseniit, Ph.D.

58:06 24_01_BoB_1280x720_Ep215

Steering Through Setbacks with AVEO Oncology's Michael Bailey

59:37 24_01_BoB_1280x720_Ep214

Leading From Within with ISCT & Kiji's Miguel Forte, M.D.

56:38 24_01_BoB_1280x720_Ep212

Expanding The Proteome with ProFound's John Lepore, M.D.

1:06:39 24_01_BoB_1280x720_Ep211

From The Bench To The Boardroom with ImmunityBio's Enrique Diloné

1:08:52 24_01_BoB_1280x720_Ep210

First AI Antibody In Humans with Aulos' Aron Knickerbocker

1:12:31 24_01_BoB_1280x720_Ep209

Drug Delivery Differentiators with Syncromune's Eamonn Hobbs

58:06 24_01_BoB_1280x720_Ep208

Topical Ocular Biologics with Claris Bio's Clarke Atwell

1:04:08 24_01_BoB_1280x720_Ep206

True DEI Value in Biopharma with Arcellx's Rami Elghandour

22:57 BoB_Ep204_Ch02

How Daiichi Sankyo Revitalized ADCs

55:45 24_01_BoB_1280x720_Ep205

Mission-Driven Dementia Funding with DDF's Jonathan Behr

26:07 BoB_Ep203_Ch02

How Is Mythic Therapeutics Transforming The ADC Space?

1:04:06 24_01_BoB_1280x720_Ep204

ADCs Ignited with Daiichi Sankyo Inc.'s Ken Keller

56:38 24_01_BoB_1280x720_Ep203

Accelerating ADCs with Mythic Therapeutics' Brian Fiske, Ph.D.

12:15 BoB_Ep196_Ch04

What's Next For Ampersand Biomedicines?

12:15 BoB_Ep196_Ch03

Marrying Computational Biology To Biotech Science

14:15 BoB_Ep196_Ch02

How Can ML And AI Improve Drug Development Success Rates?

13:55 BoB_Ep196_Ch01

Jason Gardner: From GSK To Ampersand Biomedicines CEO

22:42 BoB_Ep198_Ch03

Best Practices To Building And Funding A Successful CRISPR-Based Company

18:15 BoB_Ep198_Ch02

Ups And Downs Of The Biotech Industry

19:20 BoB_Ep198_Ch01

How Tome Biosciences' Rahul Kakkar Balances Medical Practice, Biotech Leadership, and Venture Capital Advising

7:52 BoB_Ep199_Ch02

How Orna Pioneered Circular RNA Drug Development

22:18 BoB_Ep199_Ch04

What Are The Challenges To Running An RNA Biotech?

17:19 BoB_Ep199_Ch03

What Are The Advantages Of Circular RNA?

11:25 BoB_Ep199_Ch01

How Orna Therapeutics' Tom Barnes Got Into RNA Drug Development

57:35 24_01_BoB_1280x720_Ep202

The Anti-CDMO with CTMC's Jason Bock, Ph.D. and KSQ's Thomas Leitch

11:10 BoB_Ep200_Ch03

What's Next For Anima Biotech?

30:10 BoB_Ep200_Ch02

How Can AI Revolutionize Biotech?

17:18 BoB_Ep200_Ch01

Amina Biotech's Yochi Slonim On Tech-Enabled Drug Discovery

10:12 BoB_Ep201_Ch03_2

How Can Biotech Industry Leaders Build Public Trust?

8:29 BoB_Ep201_Ch02_2

Will Direct-To-Consumer Options Solve The Drug Price Problem?

21:00 BoB_Ep201_Ch01

Why Does The Pharmaceutical Supply Chain's Last Mile Have Broken Links?

59:10 24_01_BoB_1280x720_Ep200

New Apps For AI in mRNA With Anima Biotech's Yochi Slonim

59:11 24_01_BoB_1280x720_Ep199

Circular RNA with Orna Therapeutics' Tom Barnes, Ph.D. and Advancing RNA's Anna Rose Welch

1:01:30 24_01_BoB_1280x720_Ep198

Physician + Biotech Builder with Tome Biosciences' Rahul Kakkar, M.D.

Business of Biotech Page

CELL & GENE PODCAST

18:21 Building Patient-Driven Culture and Leadership Resilience in CGT with Paul Perreault

Building Patient-Driven Culture and Leadership Resilience in CGT with Paul Perreault

26:59 Treating Inherited Retinal Disorders with Ocugen's Dr. Arun Upadhyay

Treating Inherited Retinal Disorders with Ocugen's Dr. Arun Upadhyay

34:02 Advancing Hematology and Cell Therapy Innovation with AstraZeneca's Aliya Omer

Advancing Hematology and Cell Therapy Innovation with AstraZeneca's Aliya Omer

26:23 Advancing Allogeneic Cell Therapy for SCI and Blindness with Lineage's Brian Culley

Advancing Allogeneic Cell Therapy for SCI and Blindness with Lineage's Brian Culley

21:38 How AI and ML Drive iPSC Quality with Aspen Neuroscience's Thorsten Gorba, Ph.D.

How AI and ML Drive iPSC Quality with Aspen Neuroscience's Thorsten Gorba, Ph.D.

24:15 Inside Sanofi’s Genomic Medicine Vision with Mike Quigley, Ph.D.

Inside Sanofi's Genomic Medicine Vision with Mike Quigley, Ph.D.

20:58 Engineering Off-the-Shelf Cell Therapies for Cancer & Autoimmune Disease with Ernexa Therapeutics' Sanjeev Luther

Engineering Off-The-Shelf Cell Therapies For Cancer And Autoimmune Disease With Ernexa Therapeutics' Sanjeev Luther

23:15 What Changes to FDA and CBER Mean for the Future of CGT with Daniela Drago

What Changes to FDA and CBER Mean for the Future of CGT with Daniela Drago

20:16 Inside CRISPR-GPT with Yuanhao Qu

Inside CRISPR-GPT With Yuanhao Qu

45:40 Barriers, Breakthroughs, and Building Access in Pediatric CGTs with Bambi Grilley, Ph.D.

Barriers, Breakthroughs, and Building Access in Pediatric CGTs with Bambi Grilley, Ph.D.

38:30 Defining Product Roles and Navigating FDA Approval with Monika Swietlicka

Defining Product Roles and Navigating FDA Approval with Monika Swietlicka

24:15 25_08_Cell&GeneThePodcast_1280x720_Ep109

Advancing Gene Therapy for FTD with Passage Bio's Dr. Will Chou

More Cell & Gene Podcast Videos

MOST RECENT OUTSOURCED PHARMA LIVE VIDEO

2:04 Fostering Effective Sponsor–CDMO Collaboration (Trust vs. Oversight)
Fostering Effective Sponsor–CDMO Collaboration (Trust vs. Oversight)

This segment of the Outsourced Pharma Live event, “Small Molecule Outsourcing: Getting Timelines, Tech Transfer and Analytics Right,” addresses how to balance trusting a CDMO as a subject-matter expert with maintaining sufficient oversight through cle...